4,5-dihydro-3-(hydroxymethyl)-5-phenylisoxazole | 83670-85-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4,5-dihydro-3-(hydroxymethyl)-5-phenylisoxazole
• 英文别名: (5-phenyl-4,5-dihydroisoxazol-3-yl)methanol；(5-Phenyl-4,5-dihydro-1,2-oxazol-3-yl)methanol
• CAS: 83670-85-3
• 化学式: C₁₀H₁₁NO₂
• 分子量: 177.203
• InChiKey: ZMJLEBRQBCXOFI-UHFFFAOYSA-N

物化性质

• 熔点：
  59-63 °C
• 沸点：
  307.6±52.0 °C(Predicted)
• 密度：
  1.22±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4,5-dihydro-3-(hydroxymethyl)-5-phenylisoxazole 在 W-2 Raney nickel 三氯化铝 、 氢气 、 过碘酸 作用下， 以 甲醇 、 水 为溶剂， 反应 0.5h， 生成 3-羟基-3-苯丙酸
  参考文献：
  名称：

  Methods for the stereoselective cis-cyanohydroxylation and -carboxyhydroxylation of olefins

  摘要：

  DOI：

  10.1021/jo00151a017
• 作为产物：
  描述：

  ethyl 5-phenyl-2-isoxazoline-3-carboxylate 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 反应 1.0h， 生成 4,5-dihydro-3-(hydroxymethyl)-5-phenylisoxazole
  参考文献：
  名称：

  Anti-influenza Virus Activities of 2-Alkoxyimino-N-(2-isoxazolin-3-ylmethyl)acetamides

  摘要：

  A series of 2-alkoxyimino-N-(2-isoxazolin-3-ylmethyl)acetamides and related compounds were synthesized and their antiviral activities against human influenza A virus were assessed. Studies of the structure-activity relationships revealed the strongest antiviral activity when position-5 of the isoxazoline ring was substituted with a tert-butyl group. When the alkoxyimino moiety was substituted with a methyl, ethyl, isopropyl or allyl group, good antiviral activity was obtained. Among the geometrical isomers at the oxime moiety, the E-isomers were more active than the Z-isomers. Among the compounds examined, (E)-2-allyloxyimino-2-cyano-N-(5-tert-butyl-2-iosaxazolin-3-ylmethyl)acetamide (1j) was the most active inhibitor with an EC50 of 3 mug/mL in vitro. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00362-6

文献信息

• Reaction of N,N-Dioxyenamines with Anhydrides of Carboxylic and Sulfonic Acids; A New Method for the Synthesis of α-Hydroxyoxime Derivatives
  作者：Alexey Lesiv、Andrey Tabolin、Sema Ioffe

  DOI：10.1055/s-0029-1216907

  日期：2009.9

  The reactions of N,N-dioxyenamines with carboxylic and sulfonic acid anhydrides were investigated. A new method for the synthesis of α-hydroxyoxime derivatives via the reaction of N,N-dioxyenamines with trifluoroacetic anhydride is described. 1,2-oxazine - trifluoroacetic anhydride - hydroxyoxime - enamine - rearrangement

  研究了N，N-二氧化烯胺与羧酸酐和磺酸酐的反应。描述了一种通过N，N-二氧化烯胺与三氟乙酸酐反应合成α-羟基肟衍生物的新方法。 1,2-恶嗪-三氟乙酸酐-羟基肟-烯胺-重排
• Methods for the conversion of isoxazolines to β-hydroxy ketones
  作者：Alan P. Kozikowski、Maciej Adamczyk

  DOI：10.1016/s0040-4039(00)88575-5

  日期：1982.1

  Two methods have been developed for converting isoxazolines to β-hydroxy ketones in a stereospecific manner.

  已经开发出两种方法以立体特异性方式将异恶唑啉转化为β-羟基酮。
• [EN] SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES<br/>[FR] COMPOSES HETEROCYCLIQUES SUBSTITUES UTILES POUR LE TRAITEMENT DE MALADIES CARDIO-VASCULAIRES
  申请人：CV THERAPEUTICS INC

  公开号：WO2004069818A1

  公开（公告）日：2004-08-19

  wherein: a.o. T is oxygen, sulfur, or NR11 , in which R11 is hydrogen or lower alkyl; V is -N<, -CH<, or -NH-CH<; X1 is hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; X2 is optionally substituted aryl or optionally substituted heteroaryl; Y is optionally substituted dihydroheteroarcyl; and Z1 and Z2 are independently optionally substituted alkylene of 1-4 carbon atoms, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal’s (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.

  其中：a.o. T是氧、硫或NR11，其中R11是氢或较低的烷基；V是-N<，-CH<或-NH-CH<；X1是氢，可选择取代的较低烷基，可选择取代的环烷基，可选择取代的芳基或可选择取代的杂芳基；X2是可选择取代的芳基或可选择取代的杂芳基；Y是可选择取代的二氢杂芳基；Z1和Z2分别是1-4个碳原子的可选择取代的烷基，用于治疗各种疾病状态，特别是心血管疾病，如心房和心室心律失常、间歇性跛行、普林兹梅塔（变异）心绞痛、稳定和不稳定心绞痛、运动诱发性心绞痛、充血性心脏病和心肌梗死。这些化合物还可用于治疗糖尿病。
• Isoxazole derivatives
  申请人：Yoshitomi Pharmaceutical Industries Ltd.

  公开号：US04397853A1

  公开（公告）日：1983-08-09

  Isoxazole derivatives represented by the formula ##STR1## wherein Ar, R.sup.1, R.sup.2 and Am are as defined in the specification, or salts thereof. These compounds are useful as drugs such as psychotropic agent, antiemetic agent, etc.

  该式中，Ar、R.sup.1、R.sup.2和Am的定义如规范中所述，或其盐，代表异噁唑衍生物。这些化合物可用作药物，如精神药物、止吐药等。
• Substituted heterocyclic compounds
  申请人：——

  公开号：US20040186109A1

  公开（公告）日：2004-09-23

  Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.

  本发明涉及新型杂环衍生物，可用于治疗各种疾病状态，特别是心血管疾病，如心房和心室心律失常、间歇性跛行、普林兹梅特尔（变异性）心绞痛、稳定和不稳定性心绞痛、运动诱发性心绞痛、充血性心力衰竭和心肌梗塞。该化合物还可用于治疗糖尿病。